hersenzwelling

Hersenzwelling is not a widely recognized medical diagnosis in current clinical practice. The term appears in some non-peer‑reviewed writings and speculative contexts to denote swelling of the heart, including edema of cardiac tissue, enlargement of heart chambers, or accumulation of fluid in the pericardial space. In formal medicine, these phenomena are described as cardiomegaly, myocardial edema, heart failure with congestion, or pericardial effusion rather than as hersenzwelling.

When used, the concept overlaps with established conditions such as myocarditis, ischemic heart disease, decompensated heart failure, renal failure with fluid overload, and inflammatory or autoimmune processes affecting the heart.

Possible symptoms include dyspnea, fatigue, chest discomfort, palpitations, and leg or abdominal swelling. Pericardial involvement may cause chest pain or signs of tamponade.

Diagnosis relies on standard cardiac evaluation: echocardiography for chamber size and function; MRI or CT for tissue characterization; and laboratory tests such as BNP and troponin. The term hersenzwelling itself is not required for diagnosis.

Treatment targets the underlying cause and follows established guidelines for heart failure, myocarditis, or pericardial disease, including diuretics and disease-specific therapies. Prognosis varies with the underlying condition.

Because hersenzwelling is not a formal term, its use is mainly found in fictional or speculative discussions. In medical contexts, precise terminology describing the pathogenetic process is preferred.